Evaluation of laser in situ keratomileusis for myopia at two years after surgery

张泳,廉井财,叶纹,王康孙
2000-01-01
Abstract:Objective: To evaluate the effectiveness and safety of laser in situ keratomileusis (LASIK) in treating myopia at 2 a after surgery. Methods: 98 eyes (myopia range from -4.00 D to -20.50 D, average -10.97 ± 3.54 D, astigmatism ≤ -5.00 D, average -1.61 ± 1.09 D) were treated with LASIK using Keracor 116 excimer laser. Results: Most of refraction was overcorrection just after surgery. Refraction shifted towards myopia and became rather stable 6 months after LASIK. At 2 a after LASIK, the predictability, regression and uncorrected visual acuity (UCVA) were reported. In subgroups > -15.00 D:50% of refraction was within ± 0.5 D and 63% was within ± 1 D. The average regression was -2.30 ± 1.61 D; In subgroups -10.00 D~ -15.00 D:52% ± 0.5 D, 66% ± 1 D, average regression - 1.87 ± 1.15 D. In subgroups < -10.00 D:72% ± 0.5 D, 81% ± 1 D, average regression -1.31 ± 0.90 D. There was no significant statistic difference in regression among different groups. The average UCVA were 0.55 ± 0.39, 0.77 ± 0.34, 0.99 ± 0.35. No BCVA lost more than 2 lines of international standard test chart. In subgroups ≥ -10.00 D:77% of UCVA was ≥ 0.5 and 42% of UCVA ≥ 1.0. In subgroups ≤ -10.00 D:91% UCVA ≥ 0.5, 70% UCVA ≥ 1.0. Conclusion: LASIK for myopia is safe and its effect is stable. It may he the first choice of operation for moderate or high myopia.
What problem does this paper attempt to address?